ClinicalTrials.Veeva

Menu

Graduated Elastic compRession for vAricose Veins in PrEgnancy (GRAPE)

B

Belarusian State Medical University

Status

Unknown

Conditions

Quality of Life
Pregnancy Related
Varicose Veins

Treatments

Other: Compression therapy

Study type

Observational

Funder types

Other

Identifiers

NCT05122195
20140465

Details and patient eligibility

About

This study will be evaluate the clinical efficacy of using graduated compression hosiery for venospecific symptoms, leg edema, and quality of life (QoL) in pregnant women with varicose veins (VV's).

Full description

Each pregnant woman randomly receive an envelope. Those who received numbers 01 to 40 constitute the intervention group, and those with numbers 41 to 80 are in the control group.The intervention group will use a thigh length stockings with a compression of 23-32 mmHg, at least 8 hours a day. Verbal and written instructions on the proper use of the stockings will provide. During follow-up period, monitoring the regular use of compression stockings are performed every week. The physical characteristics of the patients, including the age, height, weight, and gestational week, are obtained and recorded. The clinical evaluation are performed using clinical-etiological and anatomical-pathophysiological assessment based on the CEAP classification.

Clinical examinations, QoL assessment and duplex-ultrasound will perform two qualified physicians in the 160 lower limbs of the 80 pregnant women with VV's at three landmark periods: between the 12th and 15th (initial examination), 20th and 28th (intermediate examination), and between the 28th and 36rd (final examination) week of gestation. The study protocol includes examination of the deep and superficial venous system with recording the reflux time and great and small saphenous veins (GSV/SSV) diameters in seven preestablished points, 5 points in the GSV and 2 points in the SSV. A reflux time in the superficial veins above 0.5 s is considered pathological reflux.

The ankle and lower leg circumference are measured using a measuring tape. Measurements are carried out at the lateral and medial ankle and the middle of the lower leg. All measurements are carried out at the same time of the respective days in the late afternoon or early evening; before the measurements the patients underwent a 45-min temperature and cardiovascular equilibrium period in a sitting position.

The QoL and subjective symptoms: tired, heavy legs, sensation of tension, tingling, and pain are assessed at each visit before the volume measurements and ultrasonographic evaluation. The subjective symptoms are evaluated by use of a semiquantitative scale from 0 to 3: 0 = no symptoms; 1 = mild; 2 = moderate; and 3 = severe. The QoL is investigated at each visit by a Chronic Venous Insufficiency Questionnaire (CIVIQ).

Enrollment

80 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Pregnant women who are between the 12th and 15th weeks of gestation.
  2. Primary symptomatic varicose veins, Clinical Etiological Anatomical Pathophysiological (CEAP) classification, clinical class C1-C3.
  3. Ability to comprehend and sign an informed consent document.

Exclusion criteria

  1. Deep venous thrombosis, thrombophilia associated with a high risk of deep venous thrombosis or postthrombotic syndrome.
  2. Postoperative varicose vein disease recurrence.
  3. History of pulmonary embolism.
  4. Current compression therapy (within 7 days of enrollment).
  5. CEAP clinical class C4-C6.
  6. Arterial occlusive disease and lymphatic pathology of lower limbs.
  7. Edema of limbs other than of venous origin.

Trial design

80 participants in 2 patient groups

Group A, compression therapy group
Description:
Elastic compression therapy with a thigh length stockings of 23-32 mmHg, at least 8 hours a day.
Treatment:
Other: Compression therapy
Group B, control group
Description:
No compression therapy prescribed in the follow-up period.

Trial contacts and locations

2

Loading...

Central trial contact

Nicolay Rogovoy, MD; Vladimir Khryshchanovich

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems